Multiple genes of the renin-angiotensin system are novel targets of Wnt/β-catenin signaling

Journal of the American Society of Nephrology

Volumn 26, Issue 1, 2015, Pages 107-120

  Zhou, Lili ^a,b   Li, Yingjian ^a   Hao, Sha ^a   Zhou, Dong ^a   Tan, Roderick J ^a   Nie, Jing ^b   Hou, Fan Fan ^b   Kahn, Michael ^c   Liu, Youhua ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DOXORUBICIN; LYMPHOID ENHANCER FACTOR 1; N BENZYL 1,2,3,4,8,9 HEXAHYDRO 6 (4 HYDROXYBENZYL) 8 (1 NAPHTHYLMETHYL) 4,7 DIOXO 2H PYRAZINO[1,2 A]PYRIMIDINE 1(6H) CARBOXAMIDE; NEPHRIN; PODOCIN; WNT PROTEIN; ALBUMINOID; CREATININE; FUSED HETEROCYCLIC RINGS; LIGAND; PYRIMIDINONE DERIVATIVE; RAS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE TARGETING; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TUBULE CELL; MALE; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; ANIMAL; BAGG ALBINO MOUSE; BINDING SITE; BIOLOGY; CELL LINE; CHEMISTRY; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KIDNEY; KIDNEY TUBULE; METABOLISM; PHYSIOLOGY; PODOCYTE; WNT SIGNALING PATHWAY;

ALBUMINS; ANIMALS; BETA CATENIN; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING SITES; CELL LINE; COMPUTATIONAL BIOLOGY; CREATININE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; KIDNEY TUBULES; LIGANDS; MICE; MICE, INBRED BALB C; PODOCYTES; PROMOTER REGIONS, GENETIC; PROTEINURIA; PYRIMIDINONES; RAS PROTEINS; RENIN-ANGIOTENSIN SYSTEM; WNT SIGNALING PATHWAY;

EID: 84924090632     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014010085     Document Type: Article

References (52)

1. Ruggenenti P, Cravedi P, Remuzzi G: Mechanisms and treatment of CKD. J Am Soc Nephrol 23: 1917-1928, 2012
2. Santos PC, Krieger JE, Pereira AC: Renin-angiotensin system, hypertension, and chronic kidney disease: Pharmacogenetic implications. J Pharmacol Sci 120: 77-88, 2012
3. Crowley SD, Coffman TM: Recent advances involving the renin-angiotensin system. Exp Cell Res 318: 1049-1056, 2012
4. Cao W, Zhou QG, Nie J, Wang GB, Liu Y, Zhou ZM, Hou FF: Albumin overload activates intrarenal renin-angiotensin system through protein kinase C and NADPH oxidase-dependent pathway. J Hypertens 29: 1411-1421, 2011
5. Freundlich M, Quiroz Y, Zhang Z, Zhang Y, Bravo Y, Weisinger JR, Li YC, Rodriguez-Iturbe B: Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int 74: 1394-1402, 2008
6. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM: Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103: 17985-17990, 2006
7. Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA, Allen AM, Haase VH, Snouwaert JN, Le TH, McDonough AA, Koller BH, Coffman TM: AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab 13: 469-475, 2011
8. Chen S, Ge Y, Si J, Rifai A, Dworkin LD, Gong R: Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade. Kidney Int 74: 1128-1138, 2008
9. Reiser J, Mundel P: Dual effects of RAS blockade on blood pressure and podocyte function. Curr Hypertens Rep 9: 403-408, 2007
10. Frimodt-Møller M, Høj Nielsen A, Strandgaard S, Kamper AL: Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease. Nephrol Dial Transplant 25: 842-847, 2010
11. Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, Geng RW: Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 354: 131-140, 2006
12. Nakamura T, Fujiwara N, Kawagoe Y, Sugaya T, Ueda Y, Koide H: Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease. Eur J Clin Invest 40: 790-796, 2010
13. Müller DN, Luft FC: Direct renin inhibition with aliskiren in hypertension and target organ damage. Clin J Am Soc Nephrol 1: 221-228, 2006
14. Tan X, He W, Liu Y: Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy. Kidney Int 76: 1248-1257, 2009
15. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC: Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase. Proc Natl Acad Sci U S A 105: 15896-15901, 2008
16. Clevers H, Nusse R: Wnt/β-catenin signaling and disease. Cell 149: 1192-1205, 2012
17. Angers S, Moon RT: Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 10: 468-477, 2009
18. Schmidt-Ott KM, Barasch J: WNT/beta-catenin signaling in nephron progenitors and their epithelial progeny. Kidney Int 74: 1004-1008, 2008
19. White BD, Nguyen NK, Moon RT: Wnt signaling: It gets more humorous with age. Curr Biol 17: R923-R925, 2007
20. He W, Kang YS, Dai C, Liu Y: Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 22: 90-103, 2011
21. He W, Dai C, Li Y, Zeng G, Monga SP, Liu Y: Wnt/β-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20: 765-776, 2009
22. von Toerne C, Schmidt C, Adams J, Kiss E, Bedke J, Porubsky S, Gretz N, Lindenmeyer MT, Cohen CD, Gröne HJ, Nelson PJ: Wnt pathway regulation in chronic renal allograft damage. Am J Transplant 9: 2223-2239, 2009
23. Zhou T, He X, Cheng R, Zhang B, Zhang RR, Chen Y, Takahashi Y, Murray AR, Lee K, Gao G, Ma JX: Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy. Diabetologia 55: 255-266, 2012
24. Heikkilä E, Juhila J, Lassila M, Messing M, Perälä N, Lehtonen E, Lehtonen S, Sjef Verbeek J, Holthofer H: β-Catenin mediates adriamycin-induced albuminuria and podocyte injury in adult mouse kidneys. Nephrol Dial Transplant 25: 2437-2446, 2010
25. Surendran K, Schiavi S, Hruska KA: Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol 16: 2373-2384, 2005
26. Hao S, He W, Li Y, Ding H, Hou Y, Nie J, Hou FF, Kahn M, Liu Y: Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 22: 1642-1653, 2011
27. Henderson WR Jr., Chi EY, Ye X, Nguyen C, Tien YT, Zhou B, Borok Z, Knight DA, Kahn M: Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci U S A 107: 14309-14314, 2010
28. Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M, Moon RT, Teo JL, Kim HY, Moon SH, Ha JR, Kahn M: A small molecule inhibitor of β-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci U S A 101: 12682-12687, 2004
29. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ: Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol 296: F213-F229, 2009
30. Kang YS, Li Y, Dai C, Kiss LP, Wu C, Liu Y: Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int 78: 363-373, 2010
31. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, Liu Y: Wnt/β-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20: 1997-2008, 2009
32. Stein U, Arlt F, Walther W, Smith J, Waldman T, Harris ED, Mertins SD, Heizmann CW, Allard D, Birchmeier W, Schlag PM, Shoemaker RH: The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology 131: 1486-1500, 2006
33. Vilayur E, Harris DC: Emerging therapies for chronic kidney disease: What is their role? Nat Rev Nephrol 5: 375-383, 2009
34. Nelson PJ, von Toerne C, Gröne HJ: Wnt-signaling pathways in progressive renal fibrosis. Expert Opin Ther Targets 15: 1073-1083, 2011
35. He W, Tan R, Dai C, Li Y, Wang D, Hao S, Kahn M, Liu Y: Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/β-catenin signaling. J Biol Chem 285: 24665-24675, 2010
36. He W, Tan RJ, Li Y, Wang D, Nie J, Hou FF, Liu Y: Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD. J Am Soc Nephrol 23: 294-304, 2012
37. Zeisberg M, Neilson EG: Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21: 1819-1834, 2010
38. Boor P, Ostendorf T, Floege J: Renal fibrosis: Novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6: 643-656, 2010
39. Liu Y: Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7: 684-696, 2011
40. Gonzalez AA, Luffman C, Bourgeois CR, Vio CP, Prieto MC: Angiotensin II-independent upregulation of cyclooxygenase-2 by activation of the (Pro)renin receptor in rat renal inner medullary cells. Hypertension 61: 443-449, 2013
41. Nguyen G, Muller DN: The biology of the (pro)renin receptor. J Am Soc Nephrol 21: 18-23, 2010
42. Nguyen G: Renin and prorenin receptor in hypertension: What's new? Curr Hypertens Rep 13: 79-85, 2011
43. Feldt S, Batenburg WW, Mazak I, Maschke U, Wellner M, Kvakan H, Dechend R, Fiebeler A, Burckle C, Contrepas A, Jan Danser AH, Bader M, Nguyen G, Luft FC, Muller DN: Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension 51: 682-688, 2008
44. Huang Y, Border WA, Noble NA: Functional renin receptors in renal mesangial cells. Curr Hypertens Rep 9: 133-139, 2007
45. Hermle T, Saltukoglu D, Grünewald J, Walz G, Simons M: Regulation of Frizzled-dependent planar polarity signaling by a V-ATPase subunit. Curr Biol 20: 1269-1276, 2010
46. Cruciat CM, Ohkawara B, Acebron SP, Karaulanov E, Reinhard C, Ingelfinger D, Boutros M, Niehrs C: Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 327: 459-463, 2010
47. Locatelli F, Del Vecchio L, Cavalli A: Inhibition of the renin-angiotensin system in chronic kidney disease: A critical look to single and dual blockade. Nephron Clin Pract 113: c286-c293, 2009
48. Li Y, Tan X, Dai C, Stolz DB, Wang D, Liu Y: Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol 20: 1907-1918, 2009
49. Wang D, Dai C, Li Y, Liu Y: Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria. Kidney Int 80: 1159-1169, 2011
50. Zhou L, Li Y, Zhou D, Tan RJ, Liu Y: Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling. J Am Soc Nephrol 24: 771-785, 2013
51. Eguchi M, Nguyen C, Lee SC, Kahn M: ICG-001, a novel small molecule regulator of TCF/β-catenin transcription. Med Chem 1: 467-472, 2005
52. Ding H, Zhou D, Hao S, Zhou L, He W, Nie J, Hou FF, Liu Y: Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol 23: 801-813, 2012